Virtual Medicinal Product (VMP) - Cerliponase alfa 150mg/5ml solution for infusion vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Cerliponase alfa 150mg/5ml solution for infusion vials | Start Date 13-09-2018 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 5.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intracerebroventricular
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intracerebroventricular
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- A16AB17
| Code | Start Date | End Date |
|---|---|---|
| 35813511000001103 | 13-09-2018 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Cerliponase alfa | Based on Ingredient Substance | 30 mg | 1 ml |
Name
Cerliponase alfa
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
30.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMCerliponase alfa
-
VMP(Current) Cerliponase alfa 150mg/5ml solution ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 2 vial |